Purchase Order 75N92024P00198
Award Date 6/26/24
Potential Completion Date 8/12/24
Potential Value $540K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $274,176 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the Department of Health and Human Services, to Pacific Biosciences of California, Inc., a for-profit manufacturer. The contract is for the delivery of PacBio Revio sequencing reagents, which support the agency's genomic research initiatives. Pacific Biosciences is the original equipment manufacturer for the proprietary PacBio Sequel and Sequel II DNA/RNA sequencing...
- This is a $85,000.00 firm-fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI) to Pacific Biosciences of California, Inc. for a service contract to provide the Pacific Biosciences Revio, a new sequencing system. The contract has an ultimate completion date of July 31, 2026. Pacific Biosciences is a for-profit biotechnology company that specializes in advanced DNA and RNA sequencing technologies. This contract is not a set-aside. Pacific...
- This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Pacific Biosciences of California, Inc. for the delivery of REVIO SPRQ REAGENT KIT. The contract has a ceiling value of $137,088.00 and a period of performance through February 28, 2025. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to...
- The National Human Genome Research Institute (NHGRI) has awarded a $198,082.98 firm fixed-price purchase order to Pacific Biosciences of California, Inc. for Revio Single Molecule Real-Time (SMRT) cells and sequencing reagents. This new award, announced on September 16, 2025, with an ultimate completion date of September 26, 2026, represents a direct procurement of specialized laboratory consumables essential for advanced genomic sequencing operations. The contract carries no set-aside...
- This federal contract award is for the delivery of REVIO system parts, labor, and consumables required for repair and planned maintenance of PacBio's proprietary DNA sequencing systems. The $85,000 firm-fixed price contract was awarded to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing equipment, by a civilian federal agency, the Plains Area division. The contract does not have a set-aside designation and will run through October 17,...
- This federal contract award is for the supply and installation of a Sequel II DNA sequencing machine by Pacific Biosciences of California, Inc., a manufacturer of specialized scientific equipment. The contract, valued at $522,500.00, was awarded on May 13, 2019 by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) Office of Logistics and Acquisition Operations. The contract is a firm-fixed price purchase order with a completion date of June 9, 2019. Pacific...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- This is a $10,775.28 firm-fixed price delivery order contract awarded by the Plains Area agency of the U.S. federal government to Pacific Biosciences of California, Inc. for the provision of PacBio Revio reagents and consumables to support whole genome sequencing projects. The contract has an ultimate completion date of September 6, 2024. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are widely utilized by various...
- This federal contract award is for the delivery of PACBIO REAGENT KITS, including all reagents for sequencing 24 REVIO SMRT cells (quantity 8) and associated library prep reagents. The contract was awarded to Pacific Biosciences of California, Inc., a for-profit biotechnology company specializing in advanced DNA and RNA sequencing technologies. The contract has a ceiling value of $232,853.76 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of September 30, 2026. The...
- This contract award to Pacific Biosciences of California, Inc. is for the provision of a PacBio Sequel System 8M Upgrade. The contract, valued at $220,000.00, was awarded on a firm fixed price basis by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel...